Negotiating drug prices without restricting patient access: lessons from Germany
ADOBE
In Germany, the health care system has achieved net drug prices lower than those in the U.S. without limiting access to drugs or consumer cost sharing.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario